Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist

US Patent 7511064 · Granted Mar 31, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Illumination device for photodynamic therapy, method for treating a skin disease2025
Photodynamic therapy lamp2025
Illumination for photodynamic therapy2025
Photodynamic therapy lamp head2024
LED panel for a photodynamic therapy lamp2024
Antibody that binds to VEGF-A and ANG2 and methods of use2023
Photodynamic therapy comprising two light exposures at different wavelengths2023
Illumination device for photodynamic therapy, method for treating a skin disease2022
Illumination for photodynamic therapy2022
Bicyclic compounds as dual ATX/CA inhibitors2021
Bicyclic compounds as dual ATX/CA inhibitors2020
Bicyclic compounds as dual ATX/CA inhibitors2020